SL Science Holding Limited (SLBT) News
Follow SL Science Holding Limited (SLBT) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 17 public stories across 12 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
SL Science H1 2026 Net Loss Widens 35% to $2.16 Million
SL Science reported a 35% year-over-year widening in its H1 2026 net loss to $2.16 million.
EARNINGS | Oct 26, 2026, 08:42 PM UTC
M
SL Science Holding H1 Revenue Rises 23% to $1.39M
The company reported unaudited H1 2026 gross margin of 40.2%, up from 34.5%, and a net loss of about $2.16M versus about $1.60M. Cash was about $8.31M at June 30, after about $9.15M in financing; operating cash use was a
EARNINGS | Oct 26, 2026, 08:18 PM UTC
L
SL Science Holding Limited (SLBT) Shares Preclinical Data Showing Activity vs MGMT+ GBM
SL Science reported preclinical data showing its unmodified γδ T cells target MGMT-positive, chemotherapy-resistant glioblastoma cells, presented as poster P-2017 at the Japanese Cancer Association meeting.Material Detai
EQUITY | Sep 24, 2026, 12:01 PM UTC
L
SL Science Presents Preclinical Data at the 85th Annual Meeting of the Japanese Cancer Association Showing γδ T Cells Target Chemotherapy-Resistant Glioblastoma
New findings highlight the therapy’s ability to preferentially destroy MGMT-positive tumor cells, the specific population that survives standard treatments and drives disease recurrence.TAIPEI, Taiwan, Sept. 24, 2026 (GL
GEOPOLITICS | Sep 24, 2026, 12:01 PM UTC
L
SL Science Holding rings Nasdaq bell after IPO debut
SL Science Holding Limited rang the Nasdaq bell, marking its start as a publicly traded company and capping its active first quarter as such.
GEOPOLITICS | Sep 02, 2026, 08:17 PM UTC
L
SLBT - SL Science Holding Limited Rings Nasdaq Bell, Capping an Active First Quarter as a Publicly Traded Company
SLBT - SL Science Holding Limited Rings Nasdaq Bell, Capping an Active First Quarter as a Publicly Traded Company
EQUITY | Sep 02, 2026, 08:10 PM UTC
L
SL Science highlights new FDA drug master file for GDT exosomes
SL Science highlighted a new FDA drug master file for GDT cell-derived exosomes.
REGULATION | Aug 27, 2026, 12:07 PM UTC
L
SLB Technology highlights new FDA Drug Master File for GDT exosomes
SLB Technology said it highlighted a new FDA Drug Master File covering GDT cell-derived exosomes.
REGULATION | Aug 27, 2026, 12:00 PM UTC
L
SEC Filings: Multiple Companies
Multiple companies file with SEC
EQUITY | Aug 03, 2026, 09:28 AM UTC
L
SL Science Submits Orphan Drug Designation Request to FDA for GDT Cell Therapy in Glioblastoma
() -- SL Science (SLBT) said Friday it has submitted an orphan drug designation request to the US Food and Drug Administration for its Gamma Delta T therapy, named Vdelta2+ Gamma Delta T Cells, for the treatment of gliob
REGULATION | Jul 10, 2026, 12:20 PM UTC
L
Why Maison Solutions Shares Are Trading Higher By Over 62%; Here Are 20 Stocks Moving Premarket
Shares of Maison Solutions Inc (NASDAQ: MSS ) rose sharply in pre-market trading. Maison Solutions entered into an agreement to divest San Gabriel and Monrovia Store operations for $4.5 million as a part of strategic rea
MNA | Jul 06, 2026, 08:45 AM UTC
L
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers Seer (NASDAQ: SEER ) stock moved upwards by 33.3% to $2.16 during Thursday's after-market session. The market value of their outstanding shares is at $89.6 million. Universe Pharmaceuticals (NASDAQ: UPC ) stock m
EQUITY | Jul 02, 2026, 09:05 PM UTC
L
12 Health Care Stocks Moving In Wednesday's Intraday Session
Gainers Can Fite Biopharma (AMEX: CANF ) shares rose 43.8% to $4.27 during Wednesday's regular session. The company's market cap stands at $6.3 million. Regencell Bioscience (NASDAQ: RGC ) stock moved upwards by 35.79% t
EQUITY | Jul 01, 2026, 05:05 PM UTC
H
Nike, Shutterstock And Other Big Stocks Moving Lower In Wednesday’s Pre-Market Session
U.S. stock futures were lower this morning, with the Dow futures falling more than 100 points on Wednesday. Shares of Nike Inc (NYSE: NKE ) fell sharply in pre-market trading after the company reported fourth-quarter res
EARNINGS | Jul 01, 2026, 12:02 PM UTC
L
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers Alzamend Neuro (NASDAQ: ALZN ) stock increased by 12.9% to $1.35 during Tuesday's after-market session. The company's market cap stands at $4.4 million. Vivos Therapeutics (NASDAQ: VVOS ) shares increased by 9.92
GEOPOLITICS | Jun 30, 2026, 09:05 PM UTC
M
SLBT Falls 11.4%
SL Science Holding Ltd shares fell sharply in pre-market trading after reporting a 35% decline in net revenue and a wider net loss for the year
EARNINGS | Jun 22, 2026, 12:03 PM UTC
M
SLBT Reports FY25 Results
SL Science Holding Limited reports full year 2025 financial results
EARNINGS | Jun 18, 2026, 09:13 PM UTC